Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced the launch of the LuxSit™ Pro family of products, the world's smallest and first commercially-available de novo luciferases, which are light-emitting enzymes that use...
Mendel AI, a leader in clinical AI for the life sciences industry, announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements.
By joining NVIDIA Inception, Mendel will receive access to NVIDIA’s industry-leading technology, including the latest NVIDIA NIM inference microservices to accelerate Mendel's Hypercube AI solution,...
Digital workflows help to improve diagnostic accuracy and efficiency by integrating pathology into broader precision diagnostic systems and IT infrastructure
Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort more than in any other area of medicine. It involves a multidisciplinary team of oncologists, pathologists,...
Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, announced that it has raised €6.2 million in a seed funding round. The investment was led by Kurma Partners and Heal Capital.'
This funding will enable Spotlight Medical to...
Cognizant and Yseop, a leading artificial intelligence (AI) software company, have announced a plan to partner to help accelerate and scale the delivery of scientific content in the biopharma industry through generative AI. By utilising Yseop Copilot to transform medical writing in life sciences, the companies are hoping to enhance...
Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement.
BioGeometry is a digital biology pioneer company that specializes in AI-driven protein design and R&D platform.
Sanyou Bio is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs.
Both parties will leverage their...
AUSTIN, Texas, July 10, 2024 -- Oracle has introduced advanced features in its AI-powered Oracle Argus and Safety One Intake solutions to support life science organizations in managing regulatory requirements and increased adverse event case volumes. These new enhancements are designed to boost efficiency, enhance data privacy, and improve...
August Calhoun and Mike Allelunas are poised to advance RLDatix's strategic growth efforts and enhance operational efficiency across North America and globally.
RLDatix, the leading global provider of connected healthcare operations software and services, announces two additions to its executive leadership team. August Calhoun joins as President & General Manager of RLDatix North America, and Mike Allelunas joins as...
Exscientia plc announced it will be expanding its work with Amazon Web Services (AWS) to use the cloud provider’s artificial intelligence (AI) and machine learning (ML) services to power its platform for end-to-end drug discovery and automation.
Exscientia’s platform uses generative AI models and the scalability and flexibility of AWS...
Certara, Inc., a global leader in model-informed drug development, announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction is expected to close in the second half of 2024, subject to regulatory approval and other customary closing conditions.
Chemaxon develops leading software...
